Nucleic Acid Composition and Methods of Eliciting an Immune Response Using the Same
AssigneeTexas Biomedical Research Institute
InventorsMarie-Claire Gauduin, Philippe Blancou
Life of this patent
Estimating the term…
Loading patent…
AssigneeTexas Biomedical Research Institute
InventorsMarie-Claire Gauduin, Philippe Blancou
Estimating the term…
The present invention provides for novel compositions and methods for delivering genes of interest to stem cells using vectors that contain differentiation-specific transcriptional regulatory elements. For example, stem cells in the internal epithelia could be transfected with a vaccine construct, which has an epithelial cell differentiation-specific promoter driving the expression of viral envelope proteins. When the promoter used is specific for terminally differentiated epithelial cells, then the viral envelope proteins will be expressed only in the upper part of the epithelia and therefore, stimulate the immune response. The infected epithelial stem cells in the basal layer will continue to produce new antigen-expressing cells, without being eliminated by the immune response. This invention will be useful in the development of vaccines against viral agents that target the internal mucosa like HIV.
A nucleic acid composition comprising an expression cassette comprising a differentiation-specific transcriptional regulatory element and a viral gene of interest.
A nucleic acid composition comprising an expression cassette comprising an involucrin promoter and a gene encoding an envelope protein of a human immunodeficiency virus.
Dependencies are inferred from the claim text.